SCHEMBL5545102

SCHEMBL5545102

CC1(C(=O)O)CCC(F)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.59
MAPK1 P28482 3/20 0.37
NPSR1 Q6W5P4 2/20 0.37
TP53 P04637 1/20 0.37
NFKB1 P19838 1/20 0.37
CYP2C19 P33261 1/20 0.37
THPO P40225 1/20 0.37
STAT6 P42226 1/20 0.37
HIF1A Q16665 1/20 0.37
NPC1 O15118 1/20 0.37
GMNN O75496 1/20 0.37
LMNA P02545 1/20 0.37
MTOR P42345 1/20 0.37
RAB9A P51151 1/20 0.37
BLM P54132 1/20 0.37
PMP22 Q01453 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ALDH1A1 P00352 3/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
APLNR P35414 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28697286 0.78 FFAR3 (0.62) FFAR3MAPK1NPSR1TP53NFKB1
SCHEMBL20255525 0.78 FFAR3 (0.62) FFAR3MAPK1NPSR1TP53NFKB1
SCHEMBL9042869 0.78 FFAR3 (0.62) FFAR3MAPK1NPSR1TP53NFKB1
SCHEMBL1468704 0.78 FFAR3 (0.62) FFAR3MAPK1NPSR1TP53NFKB1
SCHEMBL10203449 0.78 FFAR3 (0.62) FFAR3MAPK1NPSR1TP53NFKB1
SCHEMBL23458958 0.78 FFAR3 (0.62) FFAR3MAPK1NPSR1TP53NFKB1
SCHEMBL9042716 0.78 FFAR3 (0.62) FFAR3MAPK1NPSR1TP53NFKB1
SCHEMBL5949421 0.78 FFAR3 (0.62) FFAR3MAPK1NPSR1TP53NFKB1
SCHEMBL139696 0.77 FFAR3 (0.54) FFAR3MAPK1NPSR1TP53NFKB1
SCHEMBL139695 0.77 FFAR3 (0.54) FFAR3MAPK1NPSR1TP53NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1806342-B1 3-CARBAMOYL-2-PYRIDONE DERIVATIVE SHIONOGI & CO (JP) 2013-04-17 EP disclosed
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed
WO-2011053948-A1 ACYLAMINO-SUBSTITUTED CYCLIC CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS SANOFI-AVENTIS (FR) 2011-05-05 WO disclosed